PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
news

HEALEY ALS Platform Trial Surpasses 50% Dosing Milestone Ahead of Schedule

129 of 240 participants dosed in Regimen I of the HEALEY ALS Platform Trial evaluating NUZ-001 Achievement follows recent expansion of Regimen I from 160 to ...
Continue Reading →
news

Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomics to Compound Screening Scale

New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates Alithea Genomic...
Continue Reading →
news

Arscience Biotherapeutics Appoints Gustavo Mahler as Chief Executive Officer

Seasoned Biopharmaceutical Leader and Board Director Steps Up to Lead the Company's Next Phase of Growth in Customised Interleukin Therapies ARScience Bio...
Continue Reading →
news

Broken String Biosciences appoints Bruce Eaton PhD as Chairman of the Board

Strengthens Board with experienced industry executive, specializing in strategic planning, organizational leadership and commercial execution Broken Strin...
Continue Reading →
news

Immunology and neurology drug development enters transformational era, says GlobalData

The landscape of both immunology and neurology therapeutics is currently undergoing a paradigm shift. Immunology therapeutics are moving beyond conventional tumo...
Continue Reading →
news

GELITA Unveils Next-Generation Excipient Innovations at BIO International 2026 in San Diego

GELITA, a global leader in collagen protein solutions, will showcase its latest advancements in excipient technology at BIO International 2026 in San Diego (Boot...
Continue Reading →
news

PhoreMost announces lead oncology programme and appoints Chief Medical Officer to support clinical entry

·       Next-generation small molecule microtubule targeting agent, PMC-001, progressing towards Phase 1 ·  ...
Continue Reading →
news

Laverock Therapeutics reports key oncology research milestones

In-vivo functional studies support lead programme selection Laverock Therapeutics ('Laverock'), a biotechnology company developing disease-responsive adva...
Continue Reading →
news

PhoreMost announces lead oncology programme and appoints Chief Medical Officer to support clinical entry

·       Next-generation small molecule microtubule targeting agent, PMC-001, progressing towards Phase 1 ·  ...
Continue Reading →
news

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance

This recognition places DFE Pharma among the top 5% of companies assessed worldwide and highlights continued progress in environmental action, labour & human...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC